Safety and Pharmacokinetics of Halix(TM) Albuterol Unit Dose Disposable Inhaler Versus Albuterol MDI

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2017

Primary Completion Date

May 28, 2018

Study Completion Date

July 25, 2018

Conditions
Asthma
Interventions
DRUG

Albuterol DPI 90mcg

Albuterol unit dose disposable DPI delivers 90mcg of albuterol in the excipient lactose with each inhalation. Albuterol 90mcg will be given on one of the 3 treatment days. One inhalation from the DPI will be used.

DRUG

Albuterol DPI 180mcg

Albuterol unit dose disposable DPI delivers 90mcg of albuterol in the excipient lactose with each inhalation. Albuterol 180mcg will be given on one of the 3 treatment days. Two inhalations from the DPI will be used to deliver the 180mcg dose

DRUG

Albuterol HFA MDI

Albuterol HFA MDI delivers 90mcg of albuterol with each inhalation. Albuterol 180mcg will be given on one of the 3 treatment days. Two inhalations from the MDI will be used to deliver the 180mcg dose

Trial Locations (1)

27607

North Carolina Clinical Research, Raleigh

All Listed Sponsors
collaborator

PharPoint Research, Inc.

INDUSTRY

collaborator

Kramer Consulting, LLC

OTHER

lead

Concentrx Pharmaceuticals, Inc.

INDUSTRY

NCT03373409 - Safety and Pharmacokinetics of Halix(TM) Albuterol Unit Dose Disposable Inhaler Versus Albuterol MDI | Biotech Hunter | Biotech Hunter